AI assistant
NovoCure Ltd — Director's Dealing 2019
Mar 4, 2019
31949_dirs_2019-03-04_b96adeca-b5aa-4441-8e57-ff91f3c719f0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-03-01
Reporting Person: Shah Pritesh (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-01 | Ordinary Shares | M | 7439 | $11.46 | Acquired | 32678 | Direct |
| 2019-03-01 | Ordinary Shares | S | 4127 | $55.233 | Disposed | 28551 | Direct |
| 2019-03-01 | Ordinary Shares | S | 3312 | $56.111 | Disposed | 25239 | Direct |
| 2019-03-01 | Ordinary Shares | M | 16250 | $7.15 | Acquired | 41489 | Direct |
| 2019-03-01 | Ordinary Shares | S | 8733 | $55.227 | Disposed | 32756 | Direct |
| 2019-03-01 | Ordinary Shares | S | 7517 | $56.097 | Disposed | 25239 | Direct |
| 2019-03-01 | Ordinary Shares | M | 16897 | $21.15 | Acquired | 42136 | Direct |
| 2019-03-01 | Ordinary Shares | S | 9161 | $55.233 | Disposed | 32975 | Direct |
| 2019-03-01 | Ordinary Shares | S | 7736 | $56.094 | Disposed | 25239 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-01 | Options to Buy Ordinary Shares | $11.46 | M | 7439 | Disposed | 2026-02-24 | Ordinary Shares (7439) | Direct |
| 2019-03-01 | Options to Buy Ordinary Shares | $7.15 | M | 16250 | Disposed | 2027-02-21 | Ordinary Shares (16250) | Direct |
| 2019-03-01 | Options to Buy Ordinary Shares | $21.15 | M | 16897 | Disposed | 2028-02-26 | Ordinary Shares (16897) | Direct |
Footnotes
F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.
F2: On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 4,127 shares in multiple trades at prices ranging from $54.64 to $55.61. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3: On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 3,312 shares in multiple trades at prices ranging from $55.72 to $56.55. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F4: On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 8,733 shares in multiple trades at prices ranging from $54.62 to $55.61. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F5: On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 7,517 shares in multiple trades at prices ranging from $55.62 to $56.56. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F6: On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 9,161 shares in multiple trades at prices ranging from $54.62 to $55.61. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F7: On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 7,736 shares in multiple trades at prices ranging from $55.62 to $56.57. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F8: Options exercised were fully vested as of the date hereof.